Cargando…

EBV-associated diseases: Current therapeutics and emerging technologies

EBV is a prevalent virus, infecting >90% of the world’s population. This is an oncogenic virus that causes ~200,000 cancer-related deaths annually. It is, in addition, a significant contributor to the burden of autoimmune diseases. Thus, EBV represents a significant public health burden. Upon inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakravorty, Srishti, Afzali, Behdad, Kazemian, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647127/
https://www.ncbi.nlm.nih.gov/pubmed/36389670
http://dx.doi.org/10.3389/fimmu.2022.1059133